Oct 15 (Reuters) - Becton Dickinson (BDX.N), opens new tab said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the ...

Becton, Dickinson and Company (NYSE:BDX) is included among the 13 Incredibly Cheap Dividend Stocks to Invest in. Becton, Dickinson and Company (NYSE:BDX), which positions itself as a medical ...

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their ...

Kovitz Investment Group Partners, LLC, an investment management company, released its “Kovitz Core Equity Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In ...

Shares of Becton Dickinson & Co. BDX slipped 1.05% to $176.37 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.60% to 6,238.01 ...

Walt Disney created Imagineering in 1952 as a place where inventors, engineers and designers could tinker with, test and innovate using the latest technology, while developing experiences and ...

Becton Dickinson’s BDX0.46%increase; green up pointing triangle plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and diagnostic solutions business ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Shares of Becton Dickinson and Co. dropped in early Monday trading after the medical-products company announced a deal to merge its biosciences and diagnostic business with Waters Corp. The deal, ...

The stock has slumped since plans to separate its bioscience and diagnostic business were announced, but the medtech company has blamed government policy for sales weakness Shares of Becton Dickinson ...

Shares of Becton Dickinson and Company (NYSE:BDX) are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting ...